微泰医疗-B |
Goldman Sachs (Asia) Corporate Holdings L.L.C. |
增持 |
9529400 |
952.94万股 |
0.15% |
好仓 |
2021-10-19 |
微泰医疗-B |
The Goldman Sachs Group, Inc. |
增持 |
9529400 |
952.94万股 |
0.15% |
好仓 |
2021-10-19 |
微泰医疗-B |
The Goldman Sachs Group, Inc. |
增持 |
2281700 |
1181.11万股 |
0.19% |
好仓 |
2021-10-19 |
微泰医疗-B |
China International Capital Corporation (Hong Kong) Limited |
增持 |
4192936 |
419.29万股 |
0.07% |
好仓 |
2021-10-19 |
世茂服务 |
Shimao Group Holdings Limited |
减持 |
-115000000 |
144235.20万股 |
0.61% |
好仓 |
2021-10-19 |
微泰医疗-B |
Invesco Advisers, Inc. |
增持 |
9249100 |
924.91万股 |
0.15% |
好仓 |
2021-10-19 |
微泰医疗-B |
UBS Fund Management (Luxembourg) S.A. |
增持 |
6305600 |
630.56万股 |
0.10% |
好仓 |
2021-10-19 |
SDM教育 |
秦蓁 |
增持 |
27000000 |
28583.20万股 |
0.65% |
好仓 |
2021-10-19 |
SDM教育 |
赵家乐 |
增持 |
27000000 |
28583.20万股 |
0.65% |
好仓 |
2021-10-19 |
微泰医疗-B |
陈飞 |
增持 |
21776804 |
2177.68万股 |
0.08% |
好仓 |
2021-10-19 |
微泰医疗-B |
于佳 |
增持 |
16055165 |
1605.52万股 |
0.06% |
好仓 |
2021-10-19 |
微泰医疗-B |
Shanghai Liyao Investment Management Co., Ltd (上海礼曜投资管理有限公司) |
增持 |
21776804 |
2177.68万股 |
0.08% |
好仓 |
2021-10-19 |
微泰医疗-B |
Shanghai Liyao Investment Management Co., Ltd (上海礼曜投资管理有限公司) |
增持 |
21776804 |
2177.68万股 |
0.08% |
好仓 |
2021-10-19 |
微泰医疗-B |
Suzhou Qiming Ronghe Venture Capital Partnership (Limited Partnership) |
增持 |
16055165 |
1605.52万股 |
0.06% |
好仓 |
2021-10-19 |
微泰医疗-B |
Suzhou Qicheng Investment Management Partnership (Limited Partnership) |
增持 |
16055165 |
1605.52万股 |
0.06% |
好仓 |
2021-10-19 |
微泰医疗-B |
Shanghai Qichang Investment Consulting Co., Ltd. |
增持 |
16055165 |
1605.52万股 |
0.06% |
好仓 |
2021-10-19 |
微泰医疗-B |
Springhill Fund Asset Management (HK) Company Limited |
增持 |
3189800 |
318.98万股 |
0.05% |
好仓 |
2021-10-19 |
微泰医疗-B |
Springhill Fund Limited |
增持 |
3189800 |
318.98万股 |
0.05% |
好仓 |
2021-10-19 |
微泰医疗-B |
Springhill Global Feeder Fund Limited |
增持 |
3189800 |
318.98万股 |
0.05% |
好仓 |
2021-10-19 |
微泰医疗-B |
Springhill Master Fund Limited |
增持 |
3189800 |
318.98万股 |
0.05% |
好仓 |
2021-10-19 |